Announcement

Collapse
No announcement yet.

GP diary: beware Tamiflu panic

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • GP diary: beware Tamiflu panic

    GP diary: beware Tamiflu panic

    Updated on 14 August 2009
    By Channel 4 News

    Dr Peter Stott, writing for Channel 4 News from his surgery in Surrey, explains why irresponsible Tamiflu use could boost the spread of swine flu.


    I was chatting about swine flu to one of my patients today and we got on to the subject of Tamiflu.
    "I've already got some," she said. "I rang the flu advice line and pretended to have symptoms. They gave me a number to get some from the chemist.
    "I wanted to take some with me on holiday just in case."
    I told her that I thought this was the height of irresponsibility and that I was surprised that one of my apparently sensible patients should have behaved in this way.
    Tamiflu works by stopping the virus multiplying in the body and it does this in a very clever way.
    Viruses are effectively parasites which use mechanisms inside human or animal cells to replicate.
    The new viruses buds off from the surface of the infected cell and is released to infect others.
    This process requires a chemical called neuraminidase and Tamiflu blocks the action of this chemical.
    So the virus cannot escape and stays inside the first cell. Tamiflu has to be taken early in the infection before too many cells have been affected.
    After this time, the host's natural immune mechanisms like interferon will kick in and give protection.
    In clinical trials Tamiflu reduces the duration of symptoms by approximately one day - a benefit that many consider may not be worth the cost and effort for patients who have only a mild illness.
    The flu virus however is very clever and very quickly develops ways to become resistant to antivirals.
    It is rather like trying to find your way to your favourite restaurant in a city centre. Even if they close one road, there are always other routes. It may take a little time to find it, but you will do eventually.
    Similarly, there are lots of types of neuraminidases - lots of ways for the virus to get out of the cell and eventually the flu virus will mutate and be able to produce one.
    We categorise neuraminidases as N1, N2, N3 etc but there are also sub-types. Swine flu is one of the H1N1viruses which are usually the nasty ones.
    Tamiflu has been used for several winters now, given to patients with normal H1N1 winter strains and we are already beginning to see signs of resistance.
    In the fourth quarter of 2008, the World Health Organisation reported that of that winter?s circulating influenza A (H1N1) flu virus, 95 per cent were resistant. We have only seen one resistant case of swine flu this year, in Denmark.
    Happily this has not spread, but the fear of scientists is that swine flu will combine with one of these resistant strains, a change which would render Tamiflu ineffective.
    So back to my patient. Why was I so upset?
    First using Tamiflu for mild cases in fit people is probably not necessary. Second, widespread use will lead to increased resistance because the virus will get used to Tamiflu and it may be ineffective when we might really need it ? if the virus mutates to become more pathogenic.
    Last, it's costing a lot of money for only minimal benefit. We have stockpiled 33m doses of Tamiflu which at normal pharmacy prices is worth over half a billion pounds - money that could be better spent on lots of other things.
    There is a direct corollary between antivirals and antibiotics. Everyone understands that antibiotics have to be used responsibly. Otherwise resistance will develop and they will become ineffective. This will inevitably happen for antivirals too.
    The government and the Department of Health have made antivirals very easily available through this flu epidemic, much more easily available than antibiotics have ever been.
    You can get them immediately, on the phone, online and without a doctor's prescription. Be assured they will be there if you need them.
    It is everyone's duty to use these medicines responsibly in the correct people, in the correct circumstance and for the correct illness.
    Not to do so will only encourage viral resistance and could as a result, put the whole population at increased risk.
    Dr Peter Stott is a GP at the Tadworth Medical Centre in Surrey.
    <!--googleoff: index-->http://www.channel4.com/news/article...+panic/3308757

  • #2
    Re: GP diary: beware Tamiflu panic

    Originally posted by niman View Post
    GP diary: beware Tamiflu panic

    Updated on 14 August 2009
    By Channel 4 News

    Similarly, there are lots of types of neuraminidases - lots of ways for the virus to get out of the cell and eventually the flu virus will mutate and be able to produce one.
    We categorise neuraminidases as N1, N2, N3 etc but there are also sub-types. Swine flu is one of the H1N1viruses which are usually the nasty ones.
    Dr Peter Stott is a GP at the Tadworth Medical Centre in Surrey.
    <!--googleoff: index-->http://www.channel4.com/news/article...+panic/3308757
    Influenza does NOT become Tamiflu resistant by changing serotypes and ALL recent H1N1 (seasonal and swine) have just ONE change, H274Y in N1 (no N2-N9 required).

    Comment


    • #3
      Re: GP diary: beware Tamiflu panic

      Originally posted by niman View Post
      GP diary: beware Tamiflu panic

      Updated on 14 August 2009
      By Channel 4 News

      Tamiflu has been used for several winters now, given to patients with normal H1N1 winter strains and we are already beginning to see signs of resistance.
      Dr Peter Stott is a GP at the Tadworth Medical Centre in Surrey.
      <!--googleoff: index-->http://www.channel4.com/news/article...+panic/3308757
      Tamiflu resistance in seasonal H1N1 is NOT linked to Tamiflu usage (in the UK or elsewhere). ALL recent resistance is due to H274Y and almost all infected patients are NOT taking Tamiflu.

      Comment


      • #4
        Re: GP diary: beware Tamiflu panic

        INFLUENZA PANDEMIC (H1N1) 2009 (32): TAMIFLU USE POLICY
        ***********************************************
        A ProMED-mail post
        <http://www.promedmail.org>
        ProMED-mail is a program of the
        International Society for Infectious Diseases
        <http://www.isid.org>

        Date: Sun 16 Aug 2009
        Source: The Guardian [edited]
        <http://www.guardian.co.uk/world/2009/aug/16/swine-flu-tamiflu-helpline-par
        acetamol>


        The government rejected advice from its expert advisers on swine flu
        [influenza pandemic (H1N1) 2009 virus], who said there was no need
        for the widespread use of Tamiflu and suggested that the public
        should simply be told to take paracetamol. An independent panel set
        up by the Department of Health warned ministers that plans to make
        the stockpiled drug widely available could do more harm than good, by
        helping the flu virus to develop resistance to the drug. But
        ministers pressed ahead with a policy of mass prescription, fearing
        the public would not tolerate being told that the millions of doses
        of Tamiflu held by the state could not be used during a pandemic, one
        of the committee members has told the Guardian [newspaper]. "It was
        felt ... it would simply be unacceptable to the UK population to tell
        them we had a huge stockpile of drugs but they were not going to be
        made available," Professor Robert Dingwall, a member of the Committee
        on Ethical Aspects of Pandemic Influenza, said. Today [16 Aug 2009]
        one of the country's foremost flu experts called for the national
        helpline to be shut down to stop hundreds of thousands of doses of
        Tamiflu going out in an unregulated way, which could render it
        useless when a more dominant strain returns in the autumn.

        As it became clear that the current outbreak only had mild symptoms,
        the committee recommended that antivirals should only be given to
        those in high risk categories, like pregnant women or people with
        existing respiratory illnesses. It suggested the government explain
        to people that they would not be given medicine they did not need and
        should use off-the-shelf flu treatments.

        "There were discussions within the Health Protection Authority and
        the Department of Health, once it became clear that swine flu was a
        relatively mild infection, about whether to reserve antivirals for
        high-risk groups and to advise the general population to treat
        themselves with paracetamol or ibuprofen," said Dingwall, director of
        the Institute for Science and Society at Nottingham University. "Some
        people wanted to take a long-term view of the risk of resistance
        developing and to seek to preserve the effectiveness of antivirals
        for the next pandemic, which may be more severe. Last month [July
        2009], the government launched the national pandemic flu service,
        which authorised more than 511 000 courses of Tamiflu and Relenza
        treatment during its 1st fortnight in operation.

        Oxford University researchers have warned that antivirals are not a
        "magic bullet" against flu and that resistance to the drug could
        develop, making it useless to fight any future and potentially more
        serious pandemic flu strain. The concern was seconded by flu expert
        Hugh Pennington, emeritus professor at Aberdeen University, who
        called for the national flu line to be shut down. "I am concerned
        about the vast amount of Tamiflu that is going out almost
        unregulated," he told the Guardian. "We are increasing the
        possibility that the flu will become resistant sooner or later. At
        the moment, there is no desperate need for Tamiflu. We should be
        reconsidering its issue rather than encouraging its use. I think we
        should stop the national pandemic flu service. It was put there for
        an outbreak of far higher mortality than we have. If you get a
        resistant strain that becomes dominant in the autumn, Tamiflu will
        then be useless."

        A senior government adviser, Prof Peter Openshaw, said the government
        was told during the early stages of the current outbreak of the
        "significant side effects" that Tamiflu was causing in some people.
        "I think there was, in some quarters, a slight over-optimism about
        the acceptability of prophylactic medication and its effectiveness,"
        said Openshaw, a member of the Scientific Advisory Group for
        Emergencies. "Maybe some of the less clinical scientific advisers
        perhaps slightly over-inflated expectations of the ease and
        efficiency of antiviral treatment. Many of us who do clinical work
        and are clinically trained had a bit more of a jaundiced view of how
        things may turn out." Openshaw said antivirals were effective only if
        used within 36 to 48 hours of symptoms developing. "If the treatment
        is delayed, they are relatively ineffective. On the other hand, we do
        have this large stockpile available, and I think there is an
        advantage in trying to treat cases early in order to reduce the
        severity and the number of patients who end up needing hospital
        care." Such a policy could "blunt" a spike of cases, reducing
        pressure on health resources, he said.

        The pandemic ethical committee was set up at the request of Sir Liam
        Donaldson, the chief medical officer, to assist planners and policy
        makers with ethical aspects of decisions they face in a pandemic,
        such as how to allocate scarce drugs when many people are sick. At
        its last meeting in May 2009, when it was already becoming clear that
        the current H1N1 strain was causing a relatively mild disease in most
        people, the committee discussed the government's antiviral strategy.
        Members feared that the widespread use of antivirals in the current
        outbreak was incompatible with the principle of minimising harm,
        minutes from the meeting show. The current outbreak did not alter the
        risk of a more serious flu pandemic developing in the future. There
        would be ethical concerns if the blanket use of antivirals
        compromised their effectiveness in the future. Members said it was
        important to use antivirals in the most appropriate way, not just
        because the government had a stockpile of the drugs. The committee
        called on the government to explain to the public that they were no
        cure for flu. The committee concluded that it would be appropriate to
        offer antivirals as treatment only for those in risk groups or with
        underlying conditions.

        In a statement, the Department of Health said: "Protecting the public
        is the prime concern of our strategy, which has been shaped by advice
        from the most eminent specialists from the beginning. There is still
        doubt about how swine flu affects people; a safety-first approach is
        the best approach. This means offering antivirals when required.
        However, we will keep this policy under review as we learn more about
        the virus and its effects. This is in line with the views of both the
        Committee on Ethical Aspects of pandemic influenza and of the
        Scientific Advisory Group for Emergencies.

        [Byline: James Sturcke]

        --
        Communicated by:
        ProMED-mail Rapporteur Mary Marshall

        [The danger inherent in the uncontrolled dispensation of the anti-
        neuraminidase antiviral Tamiflu is already evident in the sporadic
        appearance of Tamiflu-resistant viruses (for example, see the
        preceding report in this thread). In all cases so far, resistance has
        been conferred by the same H275Y mutation in the NA gene. The spread
        of Tamiflu-resistant viruses may not be long delayed if there is
        restriction in the use of this drug. Fortunately, so far, all the
        Tamiflu-resistant viruses have remained sensitive to the alternate
        anti-neuraminidase drug Relenza (zanamivir). - Mod.CP]

        [see also:
        Influenza pandemic (H1N1) 2009 (31): drug resistance 20090815.2900
        Influenza pandemic (H1N1) 2009 (30): assumptions 20090813.287
        Influenza pandemic (H1N1) 2009 (29): child treatment 20090811.2869
        Influenza pandemic (H1N1) 2009 (28): child treatment 20090811.2859
        Influenza pandemic (H1N1) 2009 (27): Viet Nam, patient data update
        20090809.2819
        Influenza pandemic (H1N1) 2009 (26): update 20090807.2801
        Influenza pandemic (H1N1) 2009 (25): Australia, UK, updates 20090806.2784
        Influenza pandemic (H1N1) 2009 (24): global update 20090805.2766
        Influenza pandemic (H1N1) 2009 (23): (China, Taiwan), co-circ. H3N2
        20090802.2713
        Influenza pandemic (H1N1) 2009 (22): Australia (NSW), swine 20090801.2698
        Influenza pandemic (H1N1) 2009 (21): vaccine priorities 20090730.2669
        Influenza pandemic (H1N1) 2009 (20): Peru, 33 percent asymptomatic
        20090730.2668
        Influenza pandemic (H1N1) 2009 (10): vaccine 20090720.2577
        Influenza pandemic (H1N1) 2009 (08): pandemic origins 20090718.2559
        Influenza pandemic (H1N1) 2009 (06): case reporting 20090717.2553
        Influenza pandemic (H1N1) 2009 (05): vaccine 20090716.2540
        Influenza pandemic (H1N1) 2009 (04): pandemic origins 20090715.2527
        Influenza pandemic (H1N1) 2009 (03): vaccine 20090713.2505
        Influenza pandemic (H1N1) 2009 (02): obesity risk factor 20090711.2482
        Influenza pandemic (H1N1) 2009 - Viet Nam: patient data 20090708.2450]
        .................................................. ..cp/msp/mpp

        Comment

        Working...
        X